Orpea: FV upgraded following Vitalis acquisition

BUY, Fair Value EUR76 vs. EUR72 (+7%)
News published on September Monday 28, 2015
Share on

Beyond the strong H1 results, Orpea’s expansion strategy is again illustrated with the acquisition of Vitalis in Germany to strengthen its platform with 2,487 recently-built beds, o/w 295 under construction, in 25 facilities. Vitalis is expected to generate EUR58m of total revenue in 2015 with an EBITDA margin of 6%. The objective in the next three years is to reach a total revenue of EUR80m with an EBITDA over 10%. Taking into account this new acquisition, which will be consolidated from January 2016, we have adjusted our estimates and move our FV to EUR76.

For more information, please contact marketing@bryangarnier.com 

The Essentials

Everything you need to know about investment banking dedicated to growth
Recent Transactions Highlights
From M&A, to IPOs see what’s been happening at Bryan, Garnier & Co this year
Join our Team
Bryan, Garnier & Co is always looking for talent in all our divisions, at all levels
Explore our opportunities